Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: A Georgia LawyerFDA to review Trial Data on Stalevo (Parkinson's drug)
The FDA said the review of Stalevo is ongoing, and no conclusions or recommendations about the use of this drug have been made. Prior trials of shorter duration evaluating Stalevo did not find an increased risk of prostate cancer.
A prior trial showed 3.7% of men who took Stalevo contracted prostate cancer, compared to 0.9% of those taking Sinemet.
Full post as published by A Georgia Lawyer on April 02, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Princeton Review
Sarasota Student Data Breach Prompts Class Action
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Agent Orange,
Heart Disease, and Parkinson's Disease may be Linked
T-mobile data plans, T-mobile, t-mobile phones
T-Mobile Faces Class Action over Limited Unlimited Data Plans
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services

New Local Web-zine, with a Focus On Parkinson's Disease
Google Guy Has Parkinson's....Mutation
Music as Medicine for the Brain
Xolair Receiving FDA Safety Review







